| Action Summary | The proposed regulatory action would amend the existing newborn screening regulation to add spinal muscular atrophy (SMA) and X-linked adrenoleukodystrophy (X-ALD) to the newborn screening panel. Blood spot newborn screening services are provided by the Department of General Services’ Division of Consolidated Laboratory Services (DCLS) in partnership with the Virginia Department of Health (VDH). SMA is a genetic disorder that is estimated to occur in approximately 9.1 out of every 100,000 live births. X-ALD is a genetic disorder that is estimated to occur in approximately 6 out of every 100,000 live births. Treatment for both X-ALD and SMA is available if detected early. Screening is necessary, as these disorders cannot be detected at birth through physical examinations. The additions of SMA and X-ALD to the newborn screening panel have been recommended by the Virginia Genetics Advisory Committee. On the national level, these disorders have been added to the core panel of 35 genetic disorders included in the Recommended Uniform Screening Panel (RUSP) of the US Secretary of Health and Human Services’ Advisory Committee on Heritable Disorders in Newborns and Children. |
| Chapters Affected | Only affects this chapter. |
| Executive Branch Review | This action will go through the normal Executive Branch Review process. |
| RIS Project | Yes [005996] |
| New Periodic Review | This action will not be used to conduct a new periodic review. |
| Name / Title: | Robin Buskey / Policy Analyst - Office of Family Health Services |
| Address: |
Virginia Department of Health 109 Governor Street Richmond, VA 23219 |
| Email Address: | Robin.Buskey@vdh.virginia.gov |
| Phone: | (804)864-7253 FAX: (804)864-7022 TDD: ()- |